NEW YORK (GenomeWeb) – ARUP Laboratories has joined PierianDx's partner network, the firms said today. ARUP will use PierianDx's workflow management tools and next-generation sequencing knowledgebase for its NGS-based clinical tests.
PierianDx was spun off earlier this year from Washington University in St. Louis. Its first product was the Clinical Genomicist Workstation, software developed by Wash U researchers, and the company also provides a knowledgebase of clinical information from thousands of previous genomic tests that its customers can tap into.
ARUP President and CEO Edward Ashwood said in a statement that PierianDx’s software and database will enable the lab to "more effectively learn from past assays and provide even more personalized recommendations to physicians so they can better match their patients to the right therapies."
In addition, PierianDx will benefit from "insight provided by ARUP clinical interpretations, variants, and related de-identified patient information," PierianDx CEO Ted Briscoe said in a statement.